299. 嚢胞性線維症 Cystic fibrosis Clinical trials / Disease details
臨床試験数 : 1,695 / 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05408910 (ClinicalTrials.gov) | July 2023 | 2/6/2022 | Rifaximin for Treatment of Bloating in Children and Adults With Cystic Fibrosis | Rifaximin for Treatment of Bloating in Children and Adults With Cystic Fibrosis | Cystic Fibrosis;Abdominal Pain;Small Bowel Disease | Drug: Rifaximin 550 MG Oral Tablet [XIFAXAN];Drug: Placebo | Wake Forest University Health Sciences | Emory University;University of Minnesota;University of Texas Southwestern Medical Center | Not yet recruiting | 12 Years | N/A | All | 100 | Phase 2/Phase 3 | United States |